Innovations in Psychosis and Schizophrenia: New Findings and Implications
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 825
Special Issue Editor
Interests: psychological assessment; mental illness; clinical psychiatry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Schizophrenia spectrum disorders (SSDs) are severe mental disorders that cause positive and negative symptoms and often lead to impaired cognitive performance, poor real-world functional outcomes, reduced quality of life, high levels of internalized stigma, low levels of life engagement, and increased mortality. They also represent a leading cause of disability worldwide and account for a substantial proportion of the use and costs of mental health services.
Considering the impact of SSDs, providing novel and further insight into their psychopathology, neurobiology, assessment, and treatment could provide valuable knowledge not only from a scientific perspective but also in clinical settings.
The present Special Issue focuses on novel findings regarding SSDs and psychosis and will publish research on psychopathology; new outcome measures and patient-reported outcomes; molecular neurobiology and neuroimaging; pharmacological treatments and psychosocial interventions; and novel conceptual insights.
Original research, systematic reviews, meta-analyses, and narrative reviews are all of interest.
Dr. Gabriele Nibbio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- schizophrenia
- psychosis
- psychopathology
- neurobiology
- assessment
- pharmacological treatment
- psychosocial interventions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
